HistoIndex

𝗪𝗲 𝗮𝗿𝗲 𝘁𝗵𝗿𝗶𝗹𝗹𝗲𝗱 𝘁𝗼 𝘀𝗵𝗮𝗿𝗲 𝘁𝗵𝗮𝘁 𝗼𝘂𝗿 𝗽𝗮𝗽𝗲𝗿, “𝗨𝘁𝗶𝗹𝗶𝘁𝘆 𝗼𝗳 𝗔𝗜 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝗮𝘀 𝗮𝗻 𝗔𝗶𝗱 𝗳𝗼𝗿 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝗶𝘀𝘁𝘀 𝗦𝗰𝗼𝗿𝗶𝗻𝗴 𝗙𝗶𝗯𝗿𝗼𝘀𝗶𝘀 𝗶𝗻 𝗠𝗔𝗦𝗛,” 𝗶𝘀 𝗻𝗼𝘄 𝗽𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗶𝗻 𝘁𝗵𝗲 Journal of Hepatology ! This milestone reflects the great teamwork and innovative ideas that emerged through years of collaboration. Special thanks to our partners from the Merck and MSD teams; Principal Investigators Professor Arun Sanyal, MD from VCU, Professor David Kleiner,MD from NIH as well as the dedicated efforts of Gideon Ho,Serene Lek, Dean Tai, Elaine Chng, PhD from the HistoIndex team. Our appreciation also goes to all the participating pathologists in this study. The paper highlights the potential of AI aiding the pathologists in enhancing concordance in histological assessments, marking a significant step forward in pathology. 📄 Read it here 👉 https://lnkd.in/g28DK7aS We are looking forward to driving impactful research with more publications on the horizon. Thank you to everyone who made this achievement possible! 🌟 #AIDigitalPathology #MASH #AIinHealthcare #collaboration

𝗪𝗿𝗮𝗽𝗽𝗶𝗻𝗴 𝗨𝗽 𝗮 𝗠𝗲𝗺𝗼𝗿𝗮𝗯𝗹𝗲 𝗔𝗔𝗦𝗟𝗗 𝟮𝟬𝟮𝟰 🌎 AASLD 2024 The Liver Meeting has officially come to a close and we are reflecting on an incredibly successful event! ✨Thank you to everyone who stopped by our booth to learn more about HistoIndex’s cutting-edge solutions in digital pathology. Your engagement and interest were truly motivating! We look forward to build on these conversations and explore new opportunities together. ✨This year, we were proud to contribute 11 poster presentations and 1 oral presentation, which sparked insightful discussions and highlighted our commitment to advancing liver disease research. ✨A highlight of the event was Histoindex's Breakfast Meeting, where we brought together a dynamic group of experts to share insights and explore the latest advancements in liver pathology, with a significant focus on MASH clinical trials. Catch the key highlights on our website! 👉 https://lnkd.in/gMiWb_ex Thank you, American Association for the Study of Liver Diseases (AASLD), for hosting another memorable event. Until next time! #AASLD2024 #TLM24 #Hepatology #LiverDiseaseResearch #DigitalPathology

✨ 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗼𝘂𝗿 𝗕𝗿𝗲𝗮𝗸𝗳𝗮𝘀𝘁 𝗥𝗲𝗰𝗲𝗽𝘁𝗶𝗼𝗻 𝗮𝘁 𝗔𝗔𝗦𝗟𝗗 𝗧𝗵𝗲 𝗟𝗶𝘃𝗲𝗿 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟰 ✨ One of the highlights of this year’s event was our 𝗕𝗿𝗲𝗮𝗸𝗳𝗮𝘀𝘁 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗼𝗻 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟭𝟱, which welcomed 𝗼𝘃𝗲𝗿 𝟳𝟬 𝗮𝘁𝘁𝗲𝗻𝗱𝗲𝗲𝘀! It was inspiring to see so many thought leaders, industry experts and clinicians come together to discuss the latest advancements in AI-based analysis. The engaging conversations about 𝗔𝗜-𝗲𝗻𝗮𝗯𝗹𝗲𝗱 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀 𝘂𝘀𝗶𝗻𝗴 𝘀𝘁𝗮𝗶𝗻-𝗳𝗿𝗲𝗲 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝗽𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 and its potential to transform patient care reaffirmed the power of collaboration and innovation in advancing liver health. A heartfelt 𝘁𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 to everyone who joined us and contributed to this incredible session! Your presence and insights made it a true success. Arun Sanyal, Mazen Noureddin, MD, MHSc, Mark Hartman, Michelle Long, David Kleiner, Michael Cooreman, Yukti Choudhury If you couldn’t attend, we’d still love to connect and share more about our work. Here’s to continuing these impactful discussions as we look ahead to #𝗘𝗔𝗦𝗟𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝟮𝟬𝟮𝟱! #AASLD2024 #TLM24 #LiverDisease #DigitalPathology #HistoIndex

🚀 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀 𝗳𝗿𝗼𝗺 𝗔𝗔𝗦𝗟𝗗 𝗧𝗵𝗲 𝗟𝗶𝘃𝗲𝗿 𝗠𝗲𝗲𝘁𝗶𝗻𝗴® 𝟮𝟬𝟮𝟰! 🚀 HistoIndex is thrilled to showcase our latest advancements in 𝗔𝗜-𝗯𝗮𝘀𝗲𝗱 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝘂𝘀𝗶𝗻𝗴 𝘀𝘁𝗮𝗶𝗻-𝗳𝗿𝗲𝗲 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝗽𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 at this year's AASLD. With 𝟭𝟮 𝗮𝗰𝗰𝗲𝗽𝘁𝗲𝗱 𝗮𝗯𝘀𝘁𝗿𝗮𝗰𝘁𝘀, we’re bringing groundbreaking insights to the liver disease community across three poster sessions, all highlighting our commitment to the study of liver diseases. 📅 𝗗𝗼𝗻’𝘁 𝗺𝗶𝘀𝘀 𝘁𝗵𝗲 𝗵𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗲𝘃𝗲𝗻𝘁: Join 𝗗𝗿. 𝗠𝗮𝗿𝘆 𝗥𝗶𝗻𝗲𝗹𝗹𝗮 on 𝗦𝘂𝗻𝗱𝗮𝘆, 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟭𝟳𝘁𝗵, from 𝟮:𝟰𝟱 𝗽𝗺 - 𝟯:𝟬𝟬 𝗽𝗺, for her oral presentation on AI-based digital pathology. She will reveal compelling results from the 𝗙𝗔𝗦𝗖𝗜𝗡𝗔𝗧𝗘-𝟮 𝘀𝘁𝘂𝗱𝘆, showing that 𝗗𝗲𝗻𝗶𝗳𝗮𝗻𝘀𝘁𝗮𝘁 improves multiple parameters of fibrosis and reduces progression to cirrhosis in MASH patients with F2/F3 fibrosis. These findings highlight how our unstained digital pathology technology platform and AI-based solutions can offer a deeper understanding of liver disease progression and treatment response, ensuring more accurate and reproducible results. A big thank you to our partners, collaborators, and the incredible HistoIndex team for making this possible. We look forward to connecting with researchers and clinicians who share our passion for innovative liver disease research. Want to learn more? Check out our press release here for details: https://shorturl.at/FpUMB See you at AASLD! Let’s push the boundaries of liver disease diagnostics, prognostics and personalized patient care. 💬 #AASLD2024 #LiverDisease #DigitalPathology #HistoIndex

Get ready for an exciting lineup at The Liver Meeting 2024! We’re thrilled to unveil our latest breakthroughs with the below 𝟭𝟮 𝗮𝗯𝘀𝘁𝗿𝗮𝗰𝘁𝘀 𝗮𝗰𝗰𝗲𝗽𝘁𝗲𝗱 𝗳𝗼𝗿 𝗼𝗿𝗮𝗹 𝗮𝗻𝗱 𝗽𝗼𝘀𝘁𝗲𝗿 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻𝘀. Join us at the American Association for the Study of Liver Diseases (AASLD) in San Diego, from November 15–18. In addition, don’t miss the chance to immerse in an interactive experience on the future of Second Harmonic Generation (SHG) technology and AI-based analytics in transforming liver disease diagnostics at our 𝗛𝗶𝘀𝘁𝗼𝗜𝗻𝗱𝗲𝘅 𝗲𝘅𝗵𝗶𝗯𝗶𝘁𝗶𝗼𝗻 𝗯𝗼𝗼𝘁𝗵 #𝟭𝟮𝟮𝟱 during AASLD — we can't wait to see you there!

Join our Breakfast Meeting at the American Association for the Study of Liver Diseases (AASLD) on Friday, 15th Nov 2024. Register here today: https://lnkd.in/gcSEcnFF

💡 Exciting advancements in liver disease care! AI-assisted pathology is set to revolutionize how we diagnose and treat fibrotic liver diseases. By enhancing the accuracy of liver biopsy evaluations and speeding up research efforts, AI can transform patient outcomes and clinical workflows. Experts like Prof. Vlad Ratziu, Dean Tai, Katy Wack, and Mathieu Petitjean share valuable insights, making this an essential read for anyone interested in liver disease innovations. Read about it here: https://lnkd.in/etpHGt6e #LiverDisease #DigitalPathology #HistoIndex

⚡ NEW: This paper by Dr. Tim Kendall, Prof. Jonathan Fallowfield, Elaine Chng, PhD, Dean Tai, and Ren Yayun dives deeper into how digital pathology, leveraging SHG/TPEF microscopy and AI analyses, is paving the way for more accurate outcome predictions in MASLD. Read the full publication here: https://lnkd.in/g-Jxkxew

Why should we care about the different methodologies to assess liver #fibrosis? While accurate staging of liver fibrosis is crucial for patient care and treatment planning, the ideal method strikes a balance between accuracy, minimal patient discomfort, and maximal clinical relevance. Learn more here: https://lnkd.in/gGvdipxs 

Watch the recap of the live discussion held during our Breakfast Meeting at EASL, featuring Dr. Arun Sanyal, Dr. Tim Kendall, and Prof. Jonathan Fallowfield, moderated by Prof. Nikolai Naoumov, where we learned more about how liver biopsies complement non-invasive tests in different patient populations, as well as the potential of AI quantification for precision medicine in MASH.